Our data demonstrate that although chromosomal microarray analysis should be the first-tier test for clinical diagnosis of chromosome abnormalities, chromosome analysis remains valuable in the ...

A large study from Children's Hospital Boston and the Boston-based Autism Consortium finds that a genetic test that samples the entire genome, known as chromosomal microarray analysis, has about ...

A new comparative genome hybridization microarray has superior resolution and a greater ability to detect chromosome abnormalities of hematologic malignancies.

The field of noninvasive prenatal testing is rapidly advancing. This review focuses on the use of genomic microarrays for the identification of chromosome anomalies in prenatal diagnosis.

A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

While innovation is happening across the genetic analysis spectrum, microarray technology will remain an important tool for genetic research labs The number of population-scale genetic research ...

Chromosomal microarray analysis, a two-year-old gene-chip technology used to look for potential genetic abnormalities in children, has proved to be remarkably sensitive in detecting abnormalities ...

We argue that this term is a misnomer, because microarray-based techniques do not reveal any details about chromosome number or structure.

Chromosomal microarray involves looking at tiny pieces of DNA to detect small duplications or missing pieces of each chromosome.

Still the analysis shows that unclear genetic findings occur in about 1% of karyotypes, so such uncertainty is not unique to microarray analysis or genome sequencing. But it’s still unsettling.

Explore the booming Chromosomal Microarray Market, projected to grow from USD 1.69 Billion in 2025 to USD 3.32 Billion by 2034, at a 10.2% CAGR. Driven by demand for advanced genetic diagnostics ...

The test, called a chromosomal microarray, detected more irregularities that could result in genetic diseases — such as missing or repeated sections of genetic code — than did karyotyping ...